Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE).

Full DD Report for ZYNE

You must become a subscriber to view this report.


Recent News from (NASDAQ: ZYNE)

Zynerba Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference
DEVON, Pa., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Zynerba’s Chief Executive Officer, A...
Source: GlobeNewswire
Date: November, 20 2018 08:00
Reading Filings to Predict Future Events
HENDERSON, NV / ACCESSWIRE / November 1, 2018 / One of the best ways to predict major announcements is by pouring through filings. Sometimes you can find interesting bits that may signal larger announcements. That's why we're so interested in CleanSpark, Inc. (CLSK). Not only have they engine...
Source: ACCESSWIRE IA
Date: November, 01 2018 10:30
Direct Selling Returns as Functional Cannabis Foods Fare Well Amid Landmark Legalization
CannabisNewsWire Editorial Coverage : All eyes are on Canada and the burgeoning North American cannabis market as the flood gates open and nationwide recreational legalization north of the U.S. border throws the recent $47.3 billion by 2027 forecast from Arcview Market Research into clear r...
Source: CannabisNewsWire
Date: October, 23 2018 09:00
Zynerba Pharmaceuticals to Present at the 2018 BIO Investor Forum
DEVON, Pa., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Armando Anido, Zynerba’s Chief Execu...
Source: GlobeNewswire
Date: October, 11 2018 10:47
The Hottest CBD Stocks
HENDERSON, NV / ACCESSWIRE / October 1, 2018 / With the DEA rescheduling CBD the top is off, and the time is now to find CBD companies before missing the boat.CBD is a very lucrative business, because just a small amount of CBD it is quite expensive.Thus making CBD business incredibly lucrat...
Source: ACCESSWIRE IA
Date: October, 01 2018 09:45
Zynerba Pharmaceuticals to Present at the Cantor Global Healthcare Conference
DEVON, Pa., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Zynerba’s Chief Executive Officer, ...
Source: GlobeNewswire
Date: September, 26 2018 09:00
Zynerba Pharmaceuticals to Present at the H.C. Wainwright 20th Annual Global Investment Conference
DEVON, Pa., Aug. 31, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Zynerba’s Chief Executive Officer, A...
Source: GlobeNewswire
Date: August, 31 2018 08:30
Premarket Gainers as of 9:05 am (08/30/2018)
KTWO +26%  on being acquired by Stryker. More news on: K2M Group Holdings, Inc., Therapix Biosciences, Network-1 Technologies, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: August, 30 2018 09:19
After Hours Gainers / Losers (08/29/2018)
Top Gainers:  GES +10.9% . TLYS +9.4% . SMTC +8.4% . ZYNE +3.2% . More news on: Guess? Inc., Tilly's, Inc., Semtech Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: August, 29 2018 17:36
Midday Gainers / Losers (08/29/2018)
Gainers: OPNT +50% . IGC +40% . GKOS +36% . EVFM +26% . IPAS +27% . SPHS +27% . AFMD +25% . JMU +19% . YRD +17% . ZYNE +17% . More news on: Opiant Pharmaceuticals, Inc., India Globalization Capital, Inc, Glaukos, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: August, 29 2018 12:48

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-087.317.337.49747.16208,755
2018-05-179.479.819.979.35248,140
2017-03-1020.5820.2720.6720.2445,112
2017-03-0920.8220.3821.172420.16226,516
2017-03-0820.0721.1121.6020.07276,003

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1129,50157,50051.3061Short
2018-12-1027,90354,93750.7909Short
2018-12-0718,26036,59449.8989Short
2018-12-0637,58857,26965.6341Short
2018-12-0443,50570,24561.9332Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ZYNE.


About Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)

Logo for Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $125,171,473 - 05/11/2018
  • Issue and Outstanding: 13,561,373 - 03/08/2018

 


Recent Filings from (NASDAQ: ZYNE)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 23 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 12 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 12 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: March, 12 2018

 

 


Daily Technical Chart for (NASDAQ: ZYNE)

Daily Technical Chart for (NASDAQ: ZYNE)


Stay tuned for daily updates and more on (NASDAQ: ZYNE)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ZYNE)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ZYNE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ZYNE and does not buy, sell, or trade any shares of ZYNE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/